ArticleInternational journal of cancer2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects.
Esther M Hollander et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.